Latest Prescription Drugs news
Retinal Neuroaxonal Loss Detectable With Epilepsy
posted October 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS
posted October 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
